Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

Medicare has undergone several major changes since it launched in 1965. And now, with the passage of the Inflation Reduction Act of 2022, it's poised to change again, with several key ...

U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

As part of the Inflation Reduction Act, price negotiations with manufacturers will begin ... (CMS), announced that 15 new drugs that are currently covered under Medicare Part D will be selected for ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...